|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.85 NGN | 0.00% |
|
0.00% | -4.64% |
Neimeth International Pharmaceuticals Plc reported earnings results for the first quarter ended December 31, 2021. For the first quarter, the company reported sales was NGN 192.11 million compared to NGN 394.56 million a year ago. Net loss was NGN 309.11 million compared to NGN 178.8 million a year ago.
Basic loss per share from continuing operations was NGN 0.16 compared to NGN 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.64% | 5.18M | |
| +32.14% | 694B | |
| +29.39% | 593B | |
| -1.57% | 371B | |
| +20.01% | 331B | |
| +7.09% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.54% | 169B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 